At 7.2% weight loss by week 12, it still delivers meaningful results comparable to what Semaglutide (Wegovy) achieves at its maximum dose
GLP-1 vs GLP-3: Understanding the Differences in Peptide Therapy The glucagon-like peptide (GLP) family has revolutionized metabolic medicine, offering powerful tools for managing diabetes, obesity, and related conditions
Immune Defence: Marks-Min Low Copper Injectable provides elements that support immune defence by aiding in the function of the immune system and white blood cells that help resist the establishment of infection (Se, Zn, Mn)
[ ] DO NOT eat, drink, or take other meds
While semaglutide is currently available, it still needs to be reviewed by the FDA for an expansion of the label
This is a medical situation, not a dosing optimization problem